The Ana Liffey Drug Project, through its Online & Digital Services team, have worked in partnership with the HSE to launch a pregabalin harm reduction campaign on the drugs.ie website. The campaign includes a webpage, fact sheet, and…

Pharmakotherapie chronischer neuropathischer Schmerzen Andreas Binder, Ralf Baron Deutsches Ärzteblatt, Jg. 113, Heft 37, 16. September 2016 https://www.aerzteblatt.de/pdf/113/37/m616.pdf

Gabapentinoids for chronic low back pain: a protocol for systematic review and meta-analysis of randomised controlled trials. Shanthanna H, Gilron I, Thabane L, Devereaux PJ, Bhandari M, AlAmri R, Rajarathinam M, Kamath S. BMJ Open. 2016 Nov 10;6(…

Review about gabapentin misuse, interactions, contraindications and side effects. Quintero GC. J Exp Pharmacol. 2017 Feb 9;9:13-21. doi: 10.2147/JEP.S124391. Review. https://www.dovepress.com/review-about-gabapentin-misuse-interactions-contraindi…

Abuse and Misuse of Pregabalin and Gabapentin. Evoy KE, Morrison MD, Saklad SR. Drugs. 2017 Feb 1. doi: 10.1007/s40265-017-0700-x. [Epub ahead of print] Review Abstract https://www.ncbi.nlm.nih.gov/pubmed/28144823

Pregabalin wurde in Deutschland 2004 zugelassen zur Behandlung von neuropathischen Schmerzen (Diabetes mell., Gürtelrose, Fibromyalgie,...), zur Behandlung der Epilepsie und bei generalisierter Angststörung. (...) - Pregabalin wirkt ä…